Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-alpha 2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?
- PMID: 16487936
- DOI: 10.1016/j.bbrc.2005.12.224
Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-alpha 2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?
Abstract
Fukuyama-type congenital muscular dystrophy (FCMD) and laminin-alpha2 deficient congenital muscular dystrophy (MDC1A) are congenital muscular dystrophies (CMDs) and they both are categorized into the same clinical entity of muscular dystrophy as Duchenne muscular dystrophy (DMD). All three disorders share a common etiologic defect in the dystrophin-glycoprotein complex, which connects muscle structural proteins with the extracellular basement membrane. To investigate the pathophysiology of these CMDs, we generated microarray gene expression profiles of skeletal muscle from patients in various clinical stages. Despite diverse pathological changes, the correlation coefficient of overall gene expression among these samples was considerably high. We performed a multi-dimensional statistical analysis, the Distillation, to extract determinant genes that distinguish CMD muscle from normal controls. Up-regulated genes were primarily extracellular matrix (ECM) components, whereas down-regulated genes included structural components of mature muscle. These observations reflect active interstitial fibrosis with less active regeneration of muscle cell components in the CMDs, characteristics that are clearly distinct from those of DMD. Although the severity of fibrosis varied among the specimens tested, ECM gene expression was consistently high without substantial changes through the clinical course. Further, in situ hybridization showed more prominent ECM gene expression on muscle cells than on interstitial tissue cells, suggesting that ECM components are induced by regeneration process rather than by 'dystrophy.' These data imply that the etiology of FCMD and MDC1A differs from that of the chronic phase of classical muscular dystrophy, and the major pathophysiologic change in CMDs might instead result from primary active fibrosis.
Similar articles
-
The childhood muscular dystrophies: making order out of chaos.Semin Neurol. 1999;19(1):9-23. doi: 10.1055/s-2008-1040822. Semin Neurol. 1999. PMID: 10711985 Review.
-
Preserved merosin M-chain (or laminin-alpha 2) expression in skeletal muscle distinguishes Walker-Warburg syndrome from Fukuyama muscular dystrophy and merosin-deficient congenital muscular dystrophy.Neuropediatrics. 1995 Jun;26(3):148-55. doi: 10.1055/s-2007-979745. Neuropediatrics. 1995. PMID: 7477753
-
Congenital muscular dystrophy with primary laminin alpha2 (merosin) deficiency presenting as inflammatory myopathy.Ann Neurol. 1996 Nov;40(5):782-91. doi: 10.1002/ana.410400515. Ann Neurol. 1996. PMID: 8957020
-
Absence of alpha 7 integrin in dystrophin-deficient mice causes a myopathy similar to Duchenne muscular dystrophy.Hum Mol Genet. 2006 Mar 15;15(6):989-98. doi: 10.1093/hmg/ddl018. Epub 2006 Feb 13. Hum Mol Genet. 2006. PMID: 16476707
-
[Muscular dystrophies due to alterations at extracellular space level: congenital muscular dystrophy caused by merosin deficiency].Rev Neurol. 1999 Jan 16-31;28(2):141-9. Rev Neurol. 1999. PMID: 10101782 Review. Spanish.
Cited by
-
Vemurafenib improves muscle histopathology in a mouse model of LAMA2-related congenital muscular dystrophy.Dis Model Mech. 2023 Jun 1;16(6):dmm049916. doi: 10.1242/dmm.049916. Epub 2023 May 10. Dis Model Mech. 2023. PMID: 37021539 Free PMC article.
-
Gene expression profiling in limb-girdle muscular dystrophy 2A.PLoS One. 2008;3(11):e3750. doi: 10.1371/journal.pone.0003750. Epub 2008 Nov 18. PLoS One. 2008. PMID: 19015733 Free PMC article.
-
Impaired Regeneration in Dystrophic Muscle-New Target for Therapy.Front Mol Neurosci. 2020 May 25;13:69. doi: 10.3389/fnmol.2020.00069. eCollection 2020. Front Mol Neurosci. 2020. PMID: 32523512 Free PMC article.
-
Muscle-specific expression of insulin-like growth factor 1 improves outcome in Lama2Dy-w mice, a model for congenital muscular dystrophy type 1A.Hum Mol Genet. 2011 Jun 15;20(12):2333-43. doi: 10.1093/hmg/ddr126. Epub 2011 Mar 26. Hum Mol Genet. 2011. PMID: 21441569 Free PMC article.
-
Laminin and Integrin in LAMA2-Related Congenital Muscular Dystrophy: From Disease to Therapeutics.Front Mol Neurosci. 2020 Feb 11;13:1. doi: 10.3389/fnmol.2020.00001. eCollection 2020. Front Mol Neurosci. 2020. PMID: 32116540 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical